S&P 500   3,246.30 (+0.29%)
DOW   26,819.99 (+0.21%)
QQQ   265.89 (+0.65%)
AAPL   108.49 (+1.28%)
MSFT   203.31 (+1.36%)
FB   249.36 (+0.14%)
GOOGL   1,420.05 (+0.76%)
AMZN   3,025.41 (+0.85%)
NVDA   493.00 (+1.66%)
TSLA   389.51 (+2.41%)
BABA   269.20 (-1.37%)
CGC   14.24 (-2.47%)
GE   6.05 (-0.98%)
MU   49.52 (-0.66%)
AMD   75.77 (+1.39%)
T   28.02 (+0.54%)
F   6.65 (+0.15%)
ACB   5.18 (+0.19%)
GILD   62.01 (-1.71%)
NFLX   472.80 (+0.47%)
DIS   122.61 (-0.54%)
BAC   23.32 (+0.26%)
BA   145.78 (-3.57%)
S&P 500   3,246.30 (+0.29%)
DOW   26,819.99 (+0.21%)
QQQ   265.89 (+0.65%)
AAPL   108.49 (+1.28%)
MSFT   203.31 (+1.36%)
FB   249.36 (+0.14%)
GOOGL   1,420.05 (+0.76%)
AMZN   3,025.41 (+0.85%)
NVDA   493.00 (+1.66%)
TSLA   389.51 (+2.41%)
BABA   269.20 (-1.37%)
CGC   14.24 (-2.47%)
GE   6.05 (-0.98%)
MU   49.52 (-0.66%)
AMD   75.77 (+1.39%)
T   28.02 (+0.54%)
F   6.65 (+0.15%)
ACB   5.18 (+0.19%)
GILD   62.01 (-1.71%)
NFLX   472.80 (+0.47%)
DIS   122.61 (-0.54%)
BAC   23.32 (+0.26%)
BA   145.78 (-3.57%)
S&P 500   3,246.30 (+0.29%)
DOW   26,819.99 (+0.21%)
QQQ   265.89 (+0.65%)
AAPL   108.49 (+1.28%)
MSFT   203.31 (+1.36%)
FB   249.36 (+0.14%)
GOOGL   1,420.05 (+0.76%)
AMZN   3,025.41 (+0.85%)
NVDA   493.00 (+1.66%)
TSLA   389.51 (+2.41%)
BABA   269.20 (-1.37%)
CGC   14.24 (-2.47%)
GE   6.05 (-0.98%)
MU   49.52 (-0.66%)
AMD   75.77 (+1.39%)
T   28.02 (+0.54%)
F   6.65 (+0.15%)
ACB   5.18 (+0.19%)
GILD   62.01 (-1.71%)
NFLX   472.80 (+0.47%)
DIS   122.61 (-0.54%)
BAC   23.32 (+0.26%)
BA   145.78 (-3.57%)
S&P 500   3,246.30 (+0.29%)
DOW   26,819.99 (+0.21%)
QQQ   265.89 (+0.65%)
AAPL   108.49 (+1.28%)
MSFT   203.31 (+1.36%)
FB   249.36 (+0.14%)
GOOGL   1,420.05 (+0.76%)
AMZN   3,025.41 (+0.85%)
NVDA   493.00 (+1.66%)
TSLA   389.51 (+2.41%)
BABA   269.20 (-1.37%)
CGC   14.24 (-2.47%)
GE   6.05 (-0.98%)
MU   49.52 (-0.66%)
AMD   75.77 (+1.39%)
T   28.02 (+0.54%)
F   6.65 (+0.15%)
ACB   5.18 (+0.19%)
GILD   62.01 (-1.71%)
NFLX   472.80 (+0.47%)
DIS   122.61 (-0.54%)
BAC   23.32 (+0.26%)
BA   145.78 (-3.57%)
Log in

Hersha Hospitality Trust (NYSE:HT) Given Average Rating of "Hold" by Brokerages

Last updated on Wednesday, September 16, 2020 | 2020 MarketBeat

Hersha Hospitality Trust (NYSE:HT) has earned a consensus recommendation of "Hold" from the nine research firms that are currently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $5.36.

A number of research firms have weighed in on HT. Stifel Nicolaus boosted their price objective on Hersha Hospitality Trust from $4.50 to $6.50 and gave the stock a "hold" rating in a research note on Friday, June 5th. Barclays boosted their price objective on Hersha Hospitality Trust from $3.00 to $6.00 and gave the stock an "underweight" rating in a research note on Monday, June 22nd. Zacks Investment Research lowered Hersha Hospitality Trust from a "hold" rating to a "sell" rating in a research note on Tuesday, June 16th. Wells Fargo & Company lowered their price objective on Hersha Hospitality Trust from $6.00 to $4.50 and set an "underweight" rating on the stock in a research note on Wednesday, July 22nd. Finally, Deutsche Bank reissued a "hold" rating and set a $4.00 price objective on shares of Hersha Hospitality Trust in a research note on Friday, August 7th.

Shares of NYSE:HT traded up $0.04 during trading on Wednesday, reaching $6.43. The stock had a trading volume of 17,307 shares, compared to its average volume of 854,611. The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.24 and a current ratio of 0.24. The business has a fifty day moving average price of $6.23 and a 200-day moving average price of $5.82. The stock has a market cap of $247.86 million, a PE ratio of -2.21 and a beta of 2.35. Hersha Hospitality Trust has a 1-year low of $2.29 and a 1-year high of $15.30.

Hersha Hospitality Trust (NYSE:HT) last issued its quarterly earnings results on Wednesday, August 5th. The real estate investment trust reported ($1.75) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.58) by ($1.17). Hersha Hospitality Trust had a negative return on equity of 11.73% and a negative net margin of 25.97%. Sell-side analysts expect that Hersha Hospitality Trust will post -1.42 earnings per share for the current year.

In other news, COO Neil H. Shah acquired 30,000 shares of the business's stock in a transaction that occurred on Wednesday, June 24th. The shares were purchased at an average price of $5.75 per share, for a total transaction of $172,500.00. Following the acquisition, the chief operating officer now owns 508,511 shares of the company's stock, valued at $2,923,938.25. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jay H. Shah acquired 20,000 shares of the business's stock in a transaction that occurred on Wednesday, June 24th. The stock was purchased at an average price of $5.63 per share, for a total transaction of $112,600.00. Following the acquisition, the chief executive officer now directly owns 464,115 shares in the company, valued at approximately $2,612,967.45. The disclosure for this purchase can be found here. Insiders purchased a total of 75,000 shares of company stock worth $414,900 in the last quarter. Company insiders own 12.90% of the company's stock.

A number of hedge funds and other institutional investors have recently modified their holdings of HT. Asio Capital LLC purchased a new stake in Hersha Hospitality Trust during the 2nd quarter worth about $29,000. NN Investment Partners Holdings N.V. purchased a new stake in Hersha Hospitality Trust during the 2nd quarter worth about $31,000. PNC Financial Services Group Inc. increased its holdings in Hersha Hospitality Trust by 244.8% during the 1st quarter. PNC Financial Services Group Inc. now owns 8,857 shares of the real estate investment trust's stock worth $32,000 after purchasing an additional 6,288 shares during the period. Envestnet Asset Management Inc. purchased a new stake in Hersha Hospitality Trust during the 1st quarter worth about $51,000. Finally, Jane Street Group LLC purchased a new stake in Hersha Hospitality Trust during the 1st quarter worth about $52,000. Institutional investors own 73.30% of the company's stock.

Hersha Hospitality Trust Company Profile

Hersha Hospitality Trust (HT) is a self-advised real estate investment trust in the hospitality sector, which owns and operates high quality upscale, luxury and lifestyle hotels in urban gateway markets and coastal destinations. The Company's 48 hotels totaling 7,644 rooms are located in New York, Washington, DC, Boston, Philadelphia, South Florida and select markets on the West Coast.

Further Reading: Buy-Side Analysts

Analyst Recommendations for Hersha Hospitality Trust (NYSE:HT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

8 Biotech Stocks to Buy and Hold in 2020

Biotech stocks are far from a sure thing. However, towards the end of 2019 several stocks in the sector got a nice lift based on promising new drugs in their pipelines. One of the key ways to measure any biotech stocks is the depth of its pipeline. When a biotech company issues a drug, its stock typically gets a lift because, for a brief period of time, the company has exclusive rights to that stock.

But those rights only last for a period of time. And at that point, generic equivalents can enter the market. Since generic labels typically bring prices down, it can be harmful to the stock unless they have a continuous stream of drugs coming to the market.

And in 2020, the story of biotech companies has been the coronavirus. Several of the leading biotech firms are working either individually or in tandem with other firms to develop vaccines or antiviral therapies to help treat and eventually blunt the spread of the virus which remains foreign to our bodies.

So while a volatile market is typically a clue to stay away from biotech stocks, now may be an ideal time to jump into this sector. And we’ve identified 8 stocks that you can buy today and hold until the end of the year.

View the "8 Biotech Stocks to Buy and Hold in 2020".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.